A Study of Fotemustine(FTM) Vs FTM and Ipilimumab (IPI) or IPI and Nivolumab in Melanoma Brain Metastasis

NCT02460068 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

168

Enrollment

OTHER

Sponsor class

Conditions

Brain Metastases

Interventions

DRUG: Fotemustine
DRUG: Fotemustine and Ipilimumab
DRUG: Ipilimumab and nivolumab

Sponsor

Italian Network for Tumor Biotherapy Foundation

Collaborators

[object Object]